Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avokal is a healthcare communications and consulting firm that provides strategic and tactical solutions for the pharmaceutical and biotechnology industries. The company specializes in contract sales forces, medical affairs support, and marketing strategy, with a particular focus on product launches and lifecycle management. Avokal helps life science clients navigate complex regulatory and market access environments through data-driven insights and specialized personnel. Their services are designed to bridge the gap between clinical development and commercial success. In July 2021, Avokal was acquired by Fishawack Health (now Avalere Health) to expand its commercialization and medical communications offerings. Following the acquisition, Avokal's capabilities were integrated into the parent company's global commercial division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avokal.